Cite

HARVARD Citation

    Borghaei, H. et al. (2018). Severe adverse events impact overall survival and costs in elderly patients with advanced non-small cell lung cancer on second-line therapy. Lung cancer. pp. 112-119. [Online]. 
  
Back to record